The Evidence Speaks (March 2021)
To mark Kidney Health Month, this edition includes the safety of dialysis during COVID-19, corticosteroid use post-kidney transplant, and prescription patterns in dialysis patients
Read MoreFebruary 24, 2021
The Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
To mark Kidney Health Month, this edition includes the safety of dialysis during COVID-19, corticosteroid use post-kidney transplant, and prescription patterns in dialysis patients
Read More
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
Read More
To mark Bell Let's Talk Day, we're focusing on mental health research from CHÉOS Scientists Drs. Chris Richardson, Anne Gadermann, Rob Stenstrom, and Joseph Puyat
Read More
This edition includes cannabis use in women with pelvic pain, the association between HPV vaccination and STIs, and anticoagulation for dialysis patients with atrial fibrillation
Read More
This edition includes deprescribing algorithms for hemodialysis patients, PROMs in fall prevention, and frailty and health after heart valve surgery
Read More
This edition includes major depressive disorder treatment coverage, social connections and hypertension, and paramedic experiences of the overdose response
Read More